Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT vs Standard Therapy for Recurrent C. difficile
NCT02255305Phase 2Terminated
- Sponsor
- Endeavor Health
- Start
- Jan 2015
- Primary completion
- Jan 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Clostridioides difficile infection (CDI), sponsored by Endeavor Health. Started Jan 2015; status: terminated.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02255305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255305.